ASPP1 and ASPP2: Common Activators of p53 Family Members

Molecular and Cellular Biology

Volumn 24, Issue 3, 2004, Pages 1341-1350

  Bergamaschi, Daniele ^a   Samuels, Yardena ^a   Jin, Boquan ^b   Duraisingham, Sai ^a   Crook, Tim ^a   Lu, Xin ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN; PROTEIN ASPP1; PROTEIN ASPP2; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PROTEIN P63; PROTEIN P73; PROTEIN PIG3; PROTEIN PUMA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RNA INTERFERENCE; TRANSACTIVATION; TUMOR GROWTH;

AMINO ACID SEQUENCE; APOPTOSIS; CARRIER PROTEINS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 1642499353     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.3.1341-1350.2004     Document Type: Article

References (24)

1. Agami, R., G. Blandino, M. Oren, and Y. Shaul. 1999. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature 399:809-813.
2. Ao, Y., L. H. Rohde, and L. Naumovski. 2001. p53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis. Oncogene 20:2720-2725.
3. Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184.
4. Balint, E., S. Bates, and K. H. Vousden. 1999. Mdm2 binds p73 alpha without targeting degradation. Oncogene 18:3923-3929.
5. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
6. Calabro, V., G. Mansueto, T. Parisi, M. Vivo, R. A. Calogero, and G. La Mantia. 2002. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J. Biol. Chem. 277:2674-2681.
7. Dobbelstein, M., and J. Roth. 1998. The large T antigen of simian virus 40 binds and inactivates p53 but not p73. J. Gen. Virol. 79:3079-3083.
8. Dobbelstein, M., S. Wienzek, C. A. Konig, and J. Roth. 1999. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene 18:2101-2106.
9. Gong, J. G., A. Costanzo, H. Q. Yang, G. Melino, W. G. Kaelin, Jr., M. Levrero, and J. Y. Wang. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806-809.
10. Gorina, S., and N. P. Pavletich. 1996. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274:1001-1005.
11. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
12. Jost, A. C., M. C. Marin, and W. G. Kaelin, Jr. 1997. p73 is a human p53-related protein that can induce apoptosis. Nature 389:191-194.
13. Kaghad, M., H. Bonnet, A. Yang, L. Creancier, J. C. Biscan, A. Valent, A. Minty, P. Chalon, J. M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
14. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by mdm2. Nature 387:299-303.
15. Marin, M. C., C. A. Jost, M. S. Irwin, J. A. DeCaprio, D. Caput, and W. G. Kaelin, Jr. 1998. Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol. 18:6316-6324.
16. Samuels-Lev, Y., D. J. O'Connor, D. Bergamaschi, G. Trigiante, J. K. Hsieh, S. Zhong, I. Campargue, L. Naumovski, T. Crook, and X. Lu. 2001. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8:781-794.
17. Scharnhorst, V., P. Dekker, A. J. van der Eb, and A. G. Jochemsen. 2000. Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions. J. Biol. Chem. 275:10202-10211.
18. Uramoto, H., H. Izumi, G. Nagatani, H. Ohmori, N. Nagasue, T. Ise, T. Yoshida, K. Yasumoto, and K. Kohno. 2003. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression. Biochem. J. 371:301-310.
19. Volgelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408:307-310.
20. Vousden, K. H., and X. Lu. 2002. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2:594-604.
21. Yang, A., M. Kaghad, D. Caput, and F. McKeon. 2002. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18:90-95.
22. Yang, A., M. Kaghad, Y. Wang, E. Gillet, M. Fleming, V. Dotsch, N. Andrews, D. Caput, and F. McKeon. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2:305-316.
23. Zeng, X., H. Lee, Q. Zhang, and H. Lu. 2001. p300 does not require its acetylase activity to stimulate p73 function. J. Biol. Chem. 276:48-52.
24. Zeng, X., X. Li, A. Miller, Z. Yuan, W. Yuan, R. P. Kwok, R. Goodman, and H. Lu. 2000. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol. Cell. Biol. 20:1299-1310.